The impacts of family planning and HIV service integration on contraceptive prevalence among HIV positive women in Tanzania: a comparative analysis from the 2016/17 Tanzania HIV impact survey.

IF 2.2 Q2 OBSTETRICS & GYNECOLOGY
Saitoti Timoth, Jane Machange, Kilaye Karino, Sally Mtenga, Abdallah Mkopi, Francis Levira
{"title":"The impacts of family planning and HIV service integration on contraceptive prevalence among HIV positive women in Tanzania: a comparative analysis from the 2016/17 Tanzania HIV impact survey.","authors":"Saitoti Timoth, Jane Machange, Kilaye Karino, Sally Mtenga, Abdallah Mkopi, Francis Levira","doi":"10.1186/s40834-023-00260-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prevention of unplanned pregnancies through modern contraceptives among HIV-positive women is one of the essential strategies for reducing mother-to-child transmission of HIV. Family planning and HIV services integration is a national strategy designed to scale-up modern contraceptives among HIV-positive women. This study aims to evaluate the success of a service integration strategy by comparing the prevalence of modern contraceptive use among HIV-positive women receiving ART within integrated services and those not on integrated services (HIV-negative women and HIV-positive women unaware of their status).</p><p><strong>Methods: </strong>We used data from the Tanzania HIV impact survey (THIS) of 2016/17. THIS provided HIV counselling and testing with a return of results in over 30,000 adults over 15 years of age. Women tested positive self reported their enrollment into ARV with further confirmation through laboratory analysis for any detectible ARV in their blood. All non-pregnant women reported their contraceptive use. Univariate and multivariate logistic regression was used to assess the effect of accessing integrated services controlling for potential confounders.</p><p><strong>Results: </strong>A total of 14,986 women were included in the analysis; HIV-positive women were 1,066 and HIV-negative women were 13,830. Modern contraceptive use prevalence was 35% among HIV-positive women and 30% among HIV-negative women. Among HIV-positive women, those enrolled in integrated services (ART) had a higher prevalence of modern contraceptive (40%) compared to HIV-positive women unaware of their status (27%, p-value = 0.0014). The most common contraceptive methods in HIV-positive women were injectables (32%) and male condoms (31%), while in HIV-negative women, injectables (39%) and implants (30%, n = 1032) were the most preferred methods. Among HIV-positive women, enrolment into integrated services (currently on ART) demonstrated an increase in the odds of modern contraceptives by 85% (AOD = 1.85, 95%CI: 1.27-2.71).</p><p><strong>Conclusion: </strong>This study found relatively low modern contraceptive use among HIV-positive women in the general population despite the existance of service integration program and guidelines to guide its implementation.Our study therefore calls for the evaluation on the implementation of the integration programme to identify factors that constrain or facilitate programme effectiveness.</p>","PeriodicalId":93956,"journal":{"name":"Contraception and reproductive medicine","volume":"8 1","pages":"58"},"PeriodicalIF":2.2000,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698873/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception and reproductive medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40834-023-00260-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prevention of unplanned pregnancies through modern contraceptives among HIV-positive women is one of the essential strategies for reducing mother-to-child transmission of HIV. Family planning and HIV services integration is a national strategy designed to scale-up modern contraceptives among HIV-positive women. This study aims to evaluate the success of a service integration strategy by comparing the prevalence of modern contraceptive use among HIV-positive women receiving ART within integrated services and those not on integrated services (HIV-negative women and HIV-positive women unaware of their status).

Methods: We used data from the Tanzania HIV impact survey (THIS) of 2016/17. THIS provided HIV counselling and testing with a return of results in over 30,000 adults over 15 years of age. Women tested positive self reported their enrollment into ARV with further confirmation through laboratory analysis for any detectible ARV in their blood. All non-pregnant women reported their contraceptive use. Univariate and multivariate logistic regression was used to assess the effect of accessing integrated services controlling for potential confounders.

Results: A total of 14,986 women were included in the analysis; HIV-positive women were 1,066 and HIV-negative women were 13,830. Modern contraceptive use prevalence was 35% among HIV-positive women and 30% among HIV-negative women. Among HIV-positive women, those enrolled in integrated services (ART) had a higher prevalence of modern contraceptive (40%) compared to HIV-positive women unaware of their status (27%, p-value = 0.0014). The most common contraceptive methods in HIV-positive women were injectables (32%) and male condoms (31%), while in HIV-negative women, injectables (39%) and implants (30%, n = 1032) were the most preferred methods. Among HIV-positive women, enrolment into integrated services (currently on ART) demonstrated an increase in the odds of modern contraceptives by 85% (AOD = 1.85, 95%CI: 1.27-2.71).

Conclusion: This study found relatively low modern contraceptive use among HIV-positive women in the general population despite the existance of service integration program and guidelines to guide its implementation.Our study therefore calls for the evaluation on the implementation of the integration programme to identify factors that constrain or facilitate programme effectiveness.

计划生育和艾滋病毒服务一体化对坦桑尼亚艾滋病毒阳性妇女避孕流行率的影响:来自2016/17坦桑尼亚艾滋病毒影响调查的比较分析
背景:通过现代避孕措施预防艾滋病毒阳性妇女的意外怀孕是减少艾滋病毒母婴传播的重要战略之一。计划生育和艾滋病毒服务一体化是一项国家战略,旨在向艾滋病毒阳性妇女推广现代避孕药具。本研究旨在通过比较在综合服务中接受抗逆转录病毒治疗的艾滋病毒阳性妇女和未接受综合服务的妇女(艾滋病毒阴性妇女和不知道自己状况的艾滋病毒阳性妇女)中使用现代避孕药具的流行程度,来评估服务综合战略的成功。方法:我们使用了2016/17年坦桑尼亚艾滋病毒影响调查(THIS)的数据。这为3万多名15岁以上的成年人提供了艾滋病毒咨询和检测,并返回了结果。检测呈阳性的妇女自我报告了她们接受抗逆转录病毒治疗的情况,并通过实验室分析进一步确认了她们血液中是否存在可检测到的抗逆转录病毒。所有未怀孕的妇女都报告了她们使用避孕药的情况。使用单变量和多变量逻辑回归来评估访问综合服务控制潜在混杂因素的效果。结果:共纳入14986名女性;艾滋病毒阳性妇女为1066人,艾滋病毒阴性妇女为13830人。现代避孕药具的使用率在艾滋病毒阳性妇女中为35%,在艾滋病毒阴性妇女中为30%。在艾滋病毒阳性妇女中,与不知道自己状况的艾滋病毒阳性妇女(27%,p值= 0.0014)相比,参加综合服务(ART)的妇女使用现代避孕药具的比例更高(40%)。在艾滋病毒阳性妇女中,最常用的避孕方法是注射(32%)和男用避孕套(31%),而在艾滋病毒阴性妇女中,注射(39%)和植入(30%,n = 1032)是最受欢迎的方法。在艾滋病毒阳性妇女中,接受综合服务(目前正在接受抗逆转录病毒治疗)的人数表明,获得现代避孕药具的几率增加了85% (AOD = 1.85, 95%CI: 1.27-2.71)。结论:本研究发现,尽管存在服务整合方案和指导实施的指南,但普通人群中艾滋病毒阳性妇女的现代避孕药具使用率相对较低。因此,我们的研究要求对一体化方案的执行情况进行评价,以确定制约或促进方案有效性的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信